PodcastsScienceThe Long Run with Luke Timmerman

The Long Run with Luke Timmerman

Timmerman Report
The Long Run with Luke Timmerman
Latest episode

191 episodes

  • The Long Run with Luke Timmerman

    Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

    22/1/2026 | 1h 5 mins.
    Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.
  • The Long Run with Luke Timmerman

    Ep192: Kate Haviland on Following the Science to Precision Immunology

    08/1/2026 | 1h 26 mins.
    Kate Haviland, former CEO of Blueprint Medicines, on how the company transitioned to a precision immunology company and was acquired by Sanofi for $9.5 billion.
  • The Long Run with Luke Timmerman

    Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

    15/12/2025 | 1h 7 mins.
    Emily Conley, CEO of Berkeley, CA-based Renasant Bio, on developing small molecule correctors and potentiators for autosomal dominant polycystic kidney disease (ADPKD).
  • The Long Run with Luke Timmerman

    Ep190: Neil Kumar on Building a Rare Disease Drug Company

    20/11/2025 | 1h 13 mins.
    Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.
  • The Long Run with Luke Timmerman

    Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI

    12/11/2025 | 1h 12 mins.
    Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.

More Science podcasts

About The Long Run with Luke Timmerman

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Podcast website

Listen to The Long Run with Luke Timmerman, Operation Night Cat and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Social
v8.3.1 | © 2007-2026 radio.de GmbH
Generated: 1/31/2026 - 2:43:00 AM